British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2024

The overall objective of the current iteration of this living guideline is to provide up-to-date, evidence-based recommendations for the management of Behçets disease/syndrome (henceforth termed ‘Behçets’ for simplicity, and as approved by the patient support group) in adults, children and young people. The document aims to: *offer an appraisal of all relevant literature up to 25 August 2023 focusing on any key developments // *address important, practical clinical questions relating to the primary guideline objective// *provide guideline recommendations and appropriate research recommendations.// The guideline is presented as a detailed review with highlighted recommendations for practical use in all appropriate community and hospital settings (see Section 3.0), in addition to a patient information leaflet (PIL; available on the BAD website: www.skinhealthinfo.org.uk).